More on TEM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $67.76 |
|
|||
| Open | $67.76 | ||||
| 52 Wk High | $0.45 | ||||
| 52 Wk Low | $0.37 | ||||
| Day High | $67.76 | ||||
| Day Low | $67.76 | ||||
| P/E | N/A | ||||
| EPS | $-0.31 | ||||
| Volume | 70,427 | ||||
- Form EFFECT Tempus AI, Inc.
- Form 424B3 Tempus AI, Inc.
- Form S-4/A Tempus AI, Inc.
- Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
- Tempus AI study shows AI pre-screening potential for lung cancer testing
- Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
- Tempus AI (TEM) Mentioned Cautiously at Spruce Point
- Tempus to Report Third Quarter 2026 Financial Results on November 2
- The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
- Ambry Genetics launches whole genome sequencing test for rare diseases
Entities mentioned with TEM
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- James Beeland Rogers Jr. | View Related Stories »
- Twitter | View Related Stories »
- Show More...
